DE2966564D1
(en)
*
|
1978-11-20 |
1984-02-23 |
American Home Prod |
Therapeutic compositions with enhanced bioavailability and process for their preparation
|
JPS55129221A
(en)
*
|
1979-03-29 |
1980-10-06 |
Kaken Pharmaceut Co Ltd |
Preparation of oral preparation containing hardly soluble medicine
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
JPS5948810B2
(ja)
*
|
1980-03-22 |
1984-11-29 |
山之内製薬株式会社 |
ニカルジピン持続性製剤用組成物
|
JPS5668609A
(en)
|
1979-11-07 |
1981-06-09 |
Nippon Kayaku Co Ltd |
Phthalazinol preparation
|
DE3033919A1
(de)
*
|
1980-09-09 |
1982-04-22 |
Bayer Ag, 5090 Leverkusen |
Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
|
EP0070127A3
(en)
*
|
1981-07-10 |
1983-08-17 |
Beecham Group Plc |
Tablets
|
USRE33963E
(en)
*
|
1981-10-29 |
1992-06-16 |
Bayer Aktiengesellschaft |
Solid rapidly released medicament preparations containing dihydropyridines, and processes for their preparation
|
DE3270785D1
(en)
*
|
1981-10-29 |
1986-05-28 |
Bayer Ag |
Process for preparing solid fast-releasing drug formulations of dihydropyridines
|
DE3142853A1
(de)
*
|
1981-10-29 |
1983-05-11 |
Bayer Ag, 5090 Leverkusen |
Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung
|
DE3381877D1
(de)
*
|
1982-03-16 |
1990-10-18 |
Univ Rockefeller |
Verwendung von opium antagonisten zur herstellung von arzneimitteln zur behebung gastro-intestinaler stoerungen.
|
DE3212736A1
(de)
*
|
1982-04-06 |
1983-10-13 |
Bayer Ag, 5090 Leverkusen |
Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
|
FR2525108B1
(fr)
*
|
1982-04-19 |
1989-05-12 |
Elan Corp Ltd |
Medicaments a haut degre de solubilite et procede pour leur obtention
|
JPS59101423A
(ja)
*
|
1982-12-02 |
1984-06-12 |
Takada Seiyaku Kk |
新規なニフエジピン固形製剤
|
DE3318649A1
(de)
*
|
1983-05-21 |
1984-11-22 |
Bayer Ag, 5090 Leverkusen |
Zweiphasenformulierung
|
JPS6038322A
(ja)
*
|
1983-08-11 |
1985-02-27 |
Fujisawa Pharmaceut Co Ltd |
ジヒドロピリジンa物質含有易溶性固形製剤
|
DE3376198D1
(en)
*
|
1983-11-30 |
1988-05-11 |
Siegfried Ag |
Therapeutic coronary composition in the form of soft gelatine capsules
|
US5948769A
(en)
*
|
1984-01-28 |
1999-09-07 |
Ismail; Roshdy |
Agent for treating heart diseases
|
EP0151989B1
(de)
*
|
1984-01-28 |
1991-04-10 |
Roshdy Dr. Ismail |
Mittel zur Behandlung von Herzerkrankungen
|
DE3580384D1
(de)
*
|
1984-04-09 |
1990-12-13 |
Toyo Boseki |
Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
|
DE3419130A1
(de)
*
|
1984-05-23 |
1985-11-28 |
Bayer Ag, 5090 Leverkusen |
Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung
|
DE3419131A1
(de)
*
|
1984-05-23 |
1985-11-28 |
Bayer Ag, 5090 Leverkusen |
Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
|
DE3419128A1
(de)
*
|
1984-05-23 |
1985-11-28 |
Bayer Ag, 5090 Leverkusen |
Dihydropyridinpraeparate und verfahren zu ihrer herstellung
|
DE3419129A1
(de)
*
|
1984-05-23 |
1985-11-28 |
Bayer Ag, 5090 Leverkusen |
Nifedipinpraeparate und verfahren zu ihrer herstellung
|
NL194389C
(nl)
*
|
1984-06-14 |
2002-03-04 |
Novartis Ag |
Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
|
US5266581A
(en)
*
|
1984-07-04 |
1993-11-30 |
Bayer Aktiengesellschaft |
Solid composition containing dihydropyridine, PVP and PVPP
|
DE3424553A1
(de)
*
|
1984-07-04 |
1986-01-09 |
Bayer Ag, 5090 Leverkusen |
Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
|
AU592065B2
(en)
*
|
1984-10-09 |
1990-01-04 |
Dow Chemical Company, The |
Sustained release dosage form based on highly plasticized cellulose ether gels
|
DE3438830A1
(de)
*
|
1984-10-23 |
1986-04-30 |
Rentschler Arzneimittel |
Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
|
US4867984A
(en)
*
|
1984-11-06 |
1989-09-19 |
Nagin K. Patel |
Drug in bead form and process for preparing same
|
DE3515335C2
(de)
*
|
1985-04-27 |
1995-01-26 |
Bayer Ag |
Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
|
IT1187751B
(it)
*
|
1985-10-15 |
1987-12-23 |
Eurand Spa |
Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
|
DE3544692A1
(de)
*
|
1985-12-18 |
1987-06-19 |
Bayer Ag |
Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
|
US4689233A
(en)
*
|
1986-01-06 |
1987-08-25 |
Siegfried Aktiengesellschaft |
Coronary therapeutic agent in the form of soft gelatin capsules
|
US4940556A
(en)
*
|
1986-01-30 |
1990-07-10 |
Syntex (U.S.A.) Inc. |
Method of preparing long acting formulation
|
US5198226A
(en)
*
|
1986-01-30 |
1993-03-30 |
Syntex (U.S.A.) Inc. |
Long acting nicardipine hydrochloride formulation
|
IE63321B1
(en)
*
|
1986-02-03 |
1995-04-05 |
Elan Corp Plc |
Drug delivery system
|
WO1987005211A1
(en)
*
|
1986-03-10 |
1987-09-11 |
Kurt Burghart |
Pharmaceutical preparation and process for producing the same
|
GB8608080D0
(en)
*
|
1986-04-02 |
1986-05-08 |
Fujisawa Pharmaceutical Co |
Solid dispersion composition
|
DE3639073A1
(de)
*
|
1986-11-14 |
1988-05-26 |
Klinge Co Chem Pharm Fab |
Feste arzneizubereitungen und verfahren zu ihrer herstellung
|
DE3682208D1
(de)
*
|
1986-12-18 |
1991-11-28 |
Kurt Heinz Bauer |
Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung.
|
US5222978A
(en)
|
1987-08-26 |
1993-06-29 |
United States Surgical Corporation |
Packaged synthetic absorbable surgical elements
|
US5366081A
(en)
|
1987-08-26 |
1994-11-22 |
United States Surgical Corporation |
Packaged synthetic absorbable surgical elements
|
US5226912A
(en)
*
|
1987-08-26 |
1993-07-13 |
United States Surgical Corporation |
Combined surgical needle-braided suture device
|
US5306289A
(en)
*
|
1987-08-26 |
1994-04-26 |
United States Surgical Corporation |
Braided suture of improved characteristics
|
US5051272A
(en)
*
|
1988-07-19 |
1991-09-24 |
United States Surgical Corporation |
Method for improving the storage stability of a polymeric article susceptible to hydrolytic degradation and resulting article
|
EP0315964B1
(en)
*
|
1987-11-11 |
1993-01-07 |
Laboratoires Pharmascience |
A novel pharmaceutical composition comprising exifone and water-soluble polymer
|
DE3829398A1
(de)
*
|
1988-08-30 |
1990-03-08 |
Rentschler Arzneimittel |
Fixe arzneimittelkombination mit verzoegerter freisetzung
|
GB8903328D0
(en)
*
|
1989-02-14 |
1989-04-05 |
Ethical Pharma Ltd |
Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
|
US5246104A
(en)
*
|
1989-08-01 |
1993-09-21 |
United States Surgical Corporation |
Molded suture retainer
|
US5359831A
(en)
|
1989-08-01 |
1994-11-01 |
United States Surgical Corporation |
Molded suture retainer
|
US5215756A
(en)
*
|
1989-12-22 |
1993-06-01 |
Gole Dilip J |
Preparation of pharmaceutical and other matrix systems by solid-state dissolution
|
JP2845342B2
(ja)
*
|
1990-04-28 |
1999-01-13 |
大正製薬株式会社 |
ビタミンd▲下3▼誘導体含有固形製剤組成物
|
ES2093106T3
(es)
*
|
1990-07-19 |
1996-12-16 |
Otsuka Pharma Co Ltd |
Preparacion solida.
|
GB9025251D0
(en)
*
|
1990-11-20 |
1991-01-02 |
Solomon Montague C |
Nifedipine dosage forms
|
CA2056032A1
(en)
*
|
1990-11-29 |
1992-05-30 |
Minoru Aoki |
Hard capsule preparation
|
US5145859A
(en)
*
|
1991-03-20 |
1992-09-08 |
Case Western Reserve University |
Methods of treating interstitial cystitis and urethral syndrome
|
GR910100193A
(el)
*
|
1991-05-03 |
1993-03-31 |
Mediventures Inc |
Παρασκευη φαρμακευτικων και αλλων περιβληματων με διαλυση σε στερεα κατασταση.
|
JP3110794B2
(ja)
*
|
1991-06-05 |
2000-11-20 |
ユーシービージャパン株式会社 |
1,4−ジヒドロピリジン誘導体を含有する製剤
|
GB9200607D0
(en)
*
|
1992-01-13 |
1992-03-11 |
Ethical Pharma Ltd |
Pharmaceutical compositions containing nifedipine and process for the preparation thereof
|
US5876754A
(en)
*
|
1992-01-17 |
1999-03-02 |
Alfatec-Pharma Gmbh |
Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
|
IL104192A
(en)
*
|
1992-02-17 |
1998-01-04 |
Siegfried Ag Pharma |
Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
|
WO1994005262A1
(en)
*
|
1992-09-10 |
1994-03-17 |
F.H. Faulding & Co. Limited |
Sustained release matrix composition
|
CZ291495B6
(cs)
*
|
1992-09-18 |
2003-03-12 |
Yamanouchi Pharmaceutical Co., Ltd. |
Hydrogelotvorný farmaceutický přípravek s prodlouženým uvolňováním
|
US5603945A
(en)
*
|
1993-02-19 |
1997-02-18 |
Takeda Chemical Industries, Ltd. |
Therapeutic/prophylactic agents and method of treating for urinary calculosis in pets
|
IS4198A
(is)
*
|
1993-08-13 |
1995-02-14 |
Somatogen, Inc |
Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
|
US5662933A
(en)
*
|
1993-09-09 |
1997-09-02 |
Edward Mendell Co., Inc. |
Controlled release formulation (albuterol)
|
US5773025A
(en)
*
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
US6726930B1
(en)
*
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US5455046A
(en)
*
|
1993-09-09 |
1995-10-03 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
SI9300504A
(en)
*
|
1993-09-28 |
1995-04-30 |
Krka |
Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
|
AU707748B2
(en)
*
|
1994-03-25 |
1999-07-22 |
Isotechnika Inc. |
Enhancement of the efficacy of drugs by deuteration
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
FR2722984B1
(fr)
*
|
1994-07-26 |
1996-10-18 |
Effik Lab |
Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
|
US5543099A
(en)
*
|
1994-09-29 |
1996-08-06 |
Hallmark Pharmaceutical, Inc. |
Process to manufacture micronized nifedipine granules for sustained release medicaments
|
WO1996011672A1
(fr)
*
|
1994-10-13 |
1996-04-25 |
Wakamoto Pharmaceutical Co., Ltd. |
Preparation lyophilisee permettant d'obtenir une composition pharmaceutique a base d'eau se transformant de maniere reversible en gel sous l'effet de la chaleur
|
NZ270439A
(en)
*
|
1995-02-02 |
1996-04-26 |
Bernard Charles Sherman |
Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
|
US5900425A
(en)
*
|
1995-05-02 |
1999-05-04 |
Bayer Aktiengesellschaft |
Pharmaceutical preparations having controlled release of active compound and processes for their preparation
|
SI9500173B
(sl)
*
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
TW487582B
(en)
*
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
DE19531684A1
(de)
*
|
1995-08-29 |
1997-03-06 |
Bayer Ag |
Verfahren zur Herstellung von Arzneimittelzubereitungen mit kontrollierter Freisetzung
|
NZ286451A
(en)
*
|
1996-04-24 |
1998-04-27 |
Bernard Charles Sherman |
Controlled release pharmaceutical composition containing granules comprising drug, water-insoluble polymer and meltable carrier
|
MX9801835A
(es)
*
|
1996-07-08 |
1998-08-30 |
Mendell Co Inc Edward |
Matriz de liberacion sostenida para medicamentos insolubles de dosis altas.
|
CA2264718C
(en)
*
|
1996-09-01 |
2006-05-30 |
Pharmos Corporation |
Solid coprecipitates for enhanced bioavailability of lipophilic substances
|
US5891469A
(en)
*
|
1997-04-02 |
1999-04-06 |
Pharmos Corporation |
Solid Coprecipitates for enhanced bioavailability of lipophilic substances
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
US5837379A
(en)
*
|
1997-01-31 |
1998-11-17 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US5922352A
(en)
*
|
1997-01-31 |
1999-07-13 |
Andrx Pharmaceuticals, Inc. |
Once daily calcium channel blocker tablet having a delayed release core
|
IN186245B
(xx)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US6056977A
(en)
*
|
1997-10-15 |
2000-05-02 |
Edward Mendell Co., Inc. |
Once-a-day controlled release sulfonylurea formulation
|
US6485748B1
(en)
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US7863331B2
(en)
|
1999-07-09 |
2011-01-04 |
Ethypharm |
Pharmaceutical composition containing fenofibrate and method for the preparation thereof
|
FR2795961B1
(fr)
|
1999-07-09 |
2004-05-28 |
Ethypharm Lab Prod Ethiques |
Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
|
KR100463496B1
(ko)
*
|
1999-09-30 |
2005-01-06 |
펜웨스트 파머슈티칼즈 컴파니 |
고가용성 약물용 서방성 메트리스 시스템
|
US20020132839A1
(en)
*
|
2000-06-22 |
2002-09-19 |
Ganter Sabina Maria |
Tablet formulations comprising valsartan
|
US6531158B1
(en)
|
2000-08-09 |
2003-03-11 |
Impax Laboratories, Inc. |
Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
|
JP3386052B2
(ja)
*
|
2001-02-13 |
2003-03-10 |
トヨタ自動車株式会社 |
ポンプ装置
|
DE10135494A1
(de)
*
|
2001-07-20 |
2003-11-06 |
Jobst Krauskopf |
Verwendung eines Lactatsalzes zur Behandlung und Prophylaxe der Athereosklerose
|
EP1400835B1
(en)
*
|
2002-09-17 |
2011-11-16 |
Nippon Telegraph And Telephone Corporation |
Semiconductor optical modulator and laser with such optical modulator
|
WO2004087102A2
(en)
*
|
2003-03-26 |
2004-10-14 |
Teva Pharmaceutical Industries Ltd. |
A process for preparing a pharmaceutical active ingredient with high specific surface area
|
CA2582767C
(en)
*
|
2004-10-25 |
2011-05-24 |
Japan Tobacco Inc. |
Solid formulation with improved solubility and stability and method for producing said formulation
|
US8133513B2
(en)
*
|
2006-03-23 |
2012-03-13 |
Shionogi & Co., Ltd. |
Solid preparation having improved solubility
|
JP7470647B2
(ja)
|
2018-06-14 |
2024-04-18 |
アストラゼネカ・ユーケイ・リミテッド |
ジヒドロピリジン型カルシウムチャネル遮断薬医薬組成物を用いて血圧を低下させるための方法
|